Between Skin and Brain: A Systematic Review of 712 Cases 1976-2025 Reveals a Highly Diverse Disease Spectrum in Chaetothyriales.

MycosesOct 30, 2026

Jiayi Li, Huaxuan Wu, Yalong Li et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined the global epidemiology, causative species, clinical presentations, and outcomes of 712 reported Chaetothyriales infections from 1976 to 2025. Cases were increasingly reported, although the authors note that improved recognition may partly explain this trend. Cladophialophora bantiana (21%), Exophiala dermatitidis (19%), and E. jeanselmei (15%) were the leading pathogens. Deep infections had higher mortality than cutaneous infections (47% vs. 7%; p < 0.001), with the highest reported mortality in central nervous system infection (58%) and disseminated disease (53%).

Key findings

  • The leading reported pathogens were Cladophialophora bantiana (21%), Exophiala dermatitidis (19%), and E. jeanselmei (15%).
  • The proportion of E. jeanselmei declined from 18%-28% in 1976-2015 to 7% in 2016-2025.
  • Mortality was higher for deep than cutaneous infections (47% vs. 7%; p < 0.001); central nervous system and disseminated infections had mortality of 58% and 53%, respectively.
  • Although 42% of infections occurred in immunocompetent individuals, transplant recipients, people with diabetes, and those with CARD9 deficiency were identified as higher-risk groups.

Why it matters

The review brings together a broad range of reported infections, from cutaneous disease to life-threatening systemic involvement. The marked mortality difference by infection depth underscores the clinical importance of recognizing invasive presentations. Its findings also show that infection is not confined to immunocompromised people, while identifying groups in whom risk may be higher.

What to keep in mind

The review is based on published case reports and cases, so reported patterns may not represent population incidence; the authors also note that increasing diagnoses may partly reflect better recognition.

Source

Published in Mycoses. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.